Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease

Patients with lung disease caused by Mycobacterium abscessus subsp. abscessus (here M. abscessus) typically have poor treatment outcomes. Although clofazimine (CFZ) has been increasingly used in the treatment of M. abscessus lung disease in clinical practice, there are no reported data on its effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Yang, Bumhee, Jhun, Byung Woo, Moon, Seong Mi, Lee, Hyun, Park, Hye Yun, Jeon, Kyeongman, Kim, Dae Hun, Kim, Su-Young, Shin, Sung Jae, Daley, Charles L., Koh, Won-Jung
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444135/
https://ncbi.nlm.nih.gov/pubmed/28348153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02052-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados